RxDoctor Payments Data

Howard Bruckner

Hematology & Oncology · Bronx, NYNPI 1760495048

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by AstraZeneca at 47.1% of the total. Reporting peaked in 2020 at $3,445 and has fallen 97.6% since, to $82 in 2024.

$5,635in general payments, 2019–2025

Across 192 payments — averaging $29.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • Ipsen Biopharmaceuticals, Inc$680
  • E.r. Squibb & Sons, L.L.C.$346
  • Genentech USA, Inc.$275
  • Rigel Pharmaceuticals, Inc.$232
  • Novartis$202
  • plus $1K from 21 others

What the payments were for

  • Consulting fees$2,90852%
  • Food & beverage$2,61646%
  • Education$1112%

General payments by program year

19
20
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,635 in reported general payments places this provider in the 65th percentile of 967 hematology & oncology providers in New York.

See all hematology & oncology providers in New York →

Other hematology & oncology in Bronx

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →